17.12.2019, 1202 Zeichen

Disclosed inside information pursuant to article 17 Market Abuse Regulation (MAR) transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.
Company Information 17.12.2019
Vienna - Austria, 17 December 2019 - The Executive Board of the Semperit AG Holding today quantified the impairment loss in the Medical Sector (Sempermed segment) at just under EUR 50 million. The earnings after taxes for Q1-3 2019 are expected to be around EUR -35 million; the annual result will be negative as well.
As announced in the ad-hoc release on 13 November 2019, the publication of the interim Group report as of 30 September was postponed. The publication date was now set for 19 December 2019.
end of announcement euro adhoc
issuer: Semperit AG Holding Modecenterstrasse 22 A-1030 Wien phone: +43 1 79 777-310 FAX: +43 1 79 777-602 mail: judit.helenyi@semperitgroup.com WWW: www.semperitgroup.com ISIN: AT0000785555 indexes: WBI, ATX GP, ATX PRIME stockmarkets: Wien language: English
Digital press kit: http://www.ots.at/pressemappe/2918/aom

Christian Drastil: Wiener Börse Plausch

Song #52: Mavie (CD-Cover)

Semperit

Bildnachweis

1. Kauf Semperit für #100100hello #goboersewien   >> Öffnen auf photaq.com

Aktien auf dem Radar:E.ON .

---

Mehr aktuelle OTS-Meldungen HIER